FITC Anti-Cytokeratin 19 antibody [A53-B/A2]
Be the first to review this product! Submit a review
|
(4 Publications)
Mouse Monoclonal Cytokeratin 19 antibody - conjugated to FITC. Suitable for Flow Cyt (Intra) and reacts with Human samples. Cited in 4 publications. Immunogen corresponding to Cell preparation containing KRT19 protein.
View Alternative Names
Cytokeratin-19, Keratin-19, CK-19, K19, KRT19, ck19, ck 19
- Flow Cyt
Supplier Data
Flow Cytometry - FITC Anti-Cytokeratin 19 antibody [A53-B/A2] (AB178543)
Separation of MCF-7 cells stained using anti-Cytokeratin 19 (A53-B/A2) FITC antibody (concentration in sample 3 ug/ml, red-filled) from MCF-7 cells stained using mouse IgG2b isotype control (MPC-11) FITC antibody (concentration in sample 3 ug/ml, same as anti-Cytokeratin 19 FITC antibody concentration, black-dashed) in flow cytometry analysis (surface staining).
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - FITC Anti-Cytokeratin 19 antibody [A53-B/A2] (AB178543)
Flow Cytometry (Intracellular) analysis of MCF-7 human breast adenocarcinoma cell line labeling Cytokeratin 19 with ab178543 at 9 μg/mL (red).
Negative control : Human peripheral whole blood (blue).
Excitation laser : 488 nm
Related conjugates and formulations (1)
-
Anti-Cytokeratin 19 antibody [A53-B/A2] - Cytoskeleton Marker
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CK19 plays a role in maintaining the cytoskeletal framework that provides mechanical support and helps control cell size and shape. It is not part of a large protein complex but works closely with other cytokeratins to ensure the stability and resilience of epithelial tissues. The A53-B/A22.26 positive staining is often used to confirm its presence in clinical histopathology.
Pathways
CK19 connects to cellular processes especially involving the keratinization and epithelial cell differentiation pathways. It interacts with other cytokeratins including BA16 and KR17 to facilitate these processes. This interaction aids in modulating the dynamics of cytoskeletal rearrangement during cell movement division and differentiation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
The Journal of neuroscience : the official journal of the Society for Neuroscience 41:3446-3461 PubMed33637560
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal of biological engineering 13:79 PubMed31673286
2019
Applications
Unspecified application
Species
Unspecified reactive species
Cell 178:160-175.e27 PubMed31155233
2019
Applications
Unspecified application
Species
Unspecified reactive species
The American journal of pathology 188:1106-1112 PubMed29454754
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com